drugset / Trial / NCT05103644

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

NCT05103644

Phase 2/3 Unknown 60 enrolled Beni-Suef University
RandomizedParallel-groupSingle-blindPrevention

Summary

Statins, a major class of drugs for treatment of hypercholesterolemia, are widely used due to a notable prevention of cardiovascular disease, and accumulating evidence proposes a promising role of statins in breast cancer

Timeline

Start
2021-10-30
Primary completion
2023-12-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg

Indications